`
`Filed: February 8, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`APOTEX INC., APOTEX CORP., APOTEX PHARMACEUTICALS
`HOLDINGS INC., AND APOTEX HOLDINGS, INC.,
`
`Petitioner,
`
`v.
`
`
`
`OSI PHARMACEUTICALS, INC.,
`
`Patent Owner.
`
`__________________
`
`Case IPR2016-01284
`Patent No. 6,900,221 B1
`__________________
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`Exhibit No.
`
`Description
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`J. Cosaert & E. Quoix, Platinum drugs in the treatment of non-
`small cell lung cancer, 87 British J. Cancer 825 (2002)
`
`Hirotsugu Kenmotsu & Yusuke Tanigawara, Pharmacokinetics,
`dynamics and toxicity of docetaxel: Why the Japanese dose
`differs from the Western dose, 106 Cancer Sci. 497 (2015)
`
`Elise A. Sudbeck et al., Tyrosine Kinase Inhibitors Against EGF
`Receptor-Positive Malignancies, 166 Methods in Molecular
`Biology 193 (2001)
`
`Center for Drug Evaluation and Research Approval Package for:
`Application Number 21-743 for Tarceva™
`
`Package Insert for Tarceva® (revised September 2016)
`
`J.R. Woodburn et al., ZD1839, an epidermal growth factor
`tyrosine kinase inhibitor selected for clinical development, 38
`Proceedings Am. Assoc. for Cancer Research 633 (1997)
`
`Cover Page and Table of Contents for Volume 105 of the Journal
`of Clinical Investigation (2000)
`
`Ramaswamy Govindan, Phase III failure rates in oncology drugs
`unacceptable, 16 Oncology News International 1 (2007)
`
`O.S. Breathnach et al., Twenty-Two Years of Phase III Trials for
`Patients with Advanced Non-Small Cell Lung Cancer: Sobering
`Results, 19 J. Clinical Oncology 1734 (2001)
`
`OSI Pharmaceuticals, Inc. 2004 Annual Report
`
`Novelos Therapeutics Discontinues Current Development
`Program for NOV-002 in NSCLC – Business Wire
`
`1
`
`
`
`
`
`Exhibit No.
`
`Description
`
`2012
`
`2013
`
`2014
`
`2015
`
`2016
`
`
`
`Novartis AG Stops Lung Cancer Drug Trial of ASA404
`Developed in Partnership with Antisoma PLC Books $120
`Million Charge
`
`OSI Pharmaceuticals, Inc. 2005 Annual Report
`
`OSI Pharmaceuticals, Inc. 2008 Annual Report
`
`Declaration of Amy K. Wigmore in Support of Motion for
`Admission Pro Hac Vice
`
`Stipulated Order Narrowing the Issues in the Litigation and IPR
`Proceeding, C.A. No. 15-772, Dkt. No. 74 (D. Del. Jan. 25,
`2017).
`
`2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served a true and
`
`correct copy of the foregoing Patent Owner’s Updated Exhibit List together with
`
`Exhibit 2016, by electronic mail on:
`
`Aaron S. Lukas
`W. Blake Coblentz
`Cozen O’Connor
`1200 19th Street, N.W.
`Washington, D.C. 20036
`Telephone No.: 202-912-4800
`wcoblentz@cozen.com
`alukas@cozen.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`__/Jonathan Ben-Ur Roses/__
`Jonathan B. Roses
`Reg. No. 61,115
`Wilmer Cutler Pickering Hale and
`Dorr LLP
`60 State Street
`Boston, MA 02109
`jonathan.roses@wilmerhale.com
`617-526-6048
`
`
`
`
`
`
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
